Treace Medical Concepts (TMCI) Income towards Parent Company (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Income towards Parent Company data on file, last reported at -$20.8 million in Q1 2026.

• Quarterly Income towards Parent Company fell 29.87% year-over-year to -$20.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.7 million (down 15.08% YoY) and the FY2025 annual result came in at -$108.0 million, down 13.84% from the prior year.
• Income towards Parent Company declined to -$20.8 million in Q1 2026, from -$7.0 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$873000.0 in Q4 2024 to a low of -$34.9 million in Q1 2022.
• A 5-year average of -$14.7 million and a median of -$15.4 million in 2024 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2022 — Income towards Parent Company soared 93.94% — and 2025, when it sank 697.37%.
• Tracing TMCI's Income towards Parent Company over 5 years: stood at -$4.1 million in 2022, then slumped by 57.26% to -$6.4 million in 2023, then soared by 86.31% to -$873000.0 in 2024, then slumped by 697.37% to -$7.0 million in 2025, then plunged by 199.47% to -$20.8 million in 2026.
• The last three Income towards Parent Company figures came in at -$20.8 million (Q1 2026), -$7.0 million (Q4 2025), and -$16.4 million (Q3 2025), per Business Quant data.